Schedule One - Glantus Holdings PLC | RNS | Ticker

Schedule One - Glantus Holdings PLC

RNS Announcement

RNS Number : 5684W

AIM

26 April 2021

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Glantus Holdings plc ("Glantus" or the "Group")

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Registered and Head office

Dublin, Ireland

Estuary House,

Block P7 Eastpoint Business Park,

Clontarf Dublin 3,

D03 Y6A2,

Ireland

Principal Trading addresses

London, United Kingdom

1 Lea Business Park

Lower Luton Road

Harpenden

AL5 5EQ

San Jose, United States

99 South Almaden Blvd.

Suite 600

San Jose

California

CA 95113

USA

COUNTRY OF INCORPORATION:

Ireland

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.glantus.com

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

Glantus is a provider of accounts payable ("AP") automation and analytics solutions. Focusing on three product areas, Active AP Discovery, Intelligent AP Automation and Advanced AP Analytics, the Group utilises its internally developed data platform to offer an integrated solution for the finance function, accounts payable in particular. These solutions are offered to over 300 customers, more than 50 of which Glantus classifies as large enterprises.

Glantus is structured around two operating units focusing on EMEA and the US which provide sales, account management, project delivery, and customer support. The Group has a shared service function which provides product development, finance, HR, compliance, marketing, strategic sales, and partnership development to the operational units.

The Group headquarters is in Dublin, Ireland. The main office for EMEA operations is in Harpenden, England . The main office for US operations is in San Jose, California.

The core product development team is based in Katowice, Poland with additional team members in a satellite office in Vilnius, Lithuania, and management support from the Dublin headquarters.

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

Number of ordinary shares of 0.001 euro each in nominal value ("Ordinary Shares") for which Admission is being sought: TBC

Placing price per Ordinary Share: TBC

There are no restrictions as to the transferability of the Ordinary Shares.

No Ordinary Shares will be held in treasury on Admission.

CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Capital to be raised : TBC (including second offering of TBC)

Anticipated market capitalisation on Admission at the placing price: TBC

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

TBC

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:

Not Applicable

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Barry Stephen Townsley (Non-Executive Chairman)

Maurice Leonard Healy (Founder & Chief Executive Officer)

Grainne McKeown (Chief Financial Officer)
Geoff Keating (Chief Technology Officer)
Diane Elizabeth Gray-Smith (Non-Executive Director)

Henry Thomas ("Tom") Price (Non-Executive Director)

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

	Before Admission	After Admission
Maurice Healy	40.3%	TBC
Geoff Keating	19.4%	TBC
Andrew Frazer	15.5%	TBC
Grainne McKeown	4.8%	TBC
Joe Keating	4.8%	TBC
MXC Guernsey Ltd	4.5%	TBC
Headspace Group Ltd	4.5%	TBC
Rosecup Investments Ltd	3.1%	TBC

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

Westhampton Financial Consulting Ltd

Hunton Andrews Kurth

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

i. 31 December

ii. 31 December 2020

iii. The first three reports published will be:

a. 30 September 2021 (half year report for the six months ending 30 June 2021)

b. 30 June 2022 (annual report and accounts for the period ending 31 December 2021)

c. 30 September 2022 (half year report for the six months ending 30 June 2022)

EXPECTED ADMISSION DATE:

Mid May

NAME AND ADDRESS OF NOMINATED ADVISER:

Arden Partners plc

125 Old Broad Street

London

EC2N 1AR

NAME AND ADDRESS OF BROKER:

Arden Partners plc

125 Old Broad Street

London

EC2N 1AR

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

The admission document will be available from the Company's registered office, Estuary House, Block P7 Eastpoint Business Park, Clontarf Dublin 3, D03 Y6A2, Ireland

A digital copy of the admission document, containing full details about the applicant and the admission of its securities will be available on the Company's website at:

www.glantus.com

THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY

QCA Corporate Governance Code

DATE OF NOTIFICATION:

26 April 2021

NEW/ UPDATE:

NEW

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PAAEAPLKAFAFEEA

RNS metadata

Title: Schedule One - Glantus Holdings PLC
Time: 10:00:05
Date: 26 Apr 2021
Category: Capital structure
ID: 5684W